Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Clinical Course of Chronic Hepatitis B Infection in Patients With Inflammatory Bowel Disease and Rheumatologic Disease on Immunosuppressive Therapy

NCT02128503 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT02128503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02128503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Clinical Course of Chronic Hepatitis B Infection in Patients With Inflammatory Bowel Disease and Rheumatologic Disease on Immunosuppressive Therapy
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2013
Completion date
October 16, 2015
Enrollment
430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, hepatitis b, chronic, inflammatory bowel disease, rheumatic diseases, ulcerative colitis